References
Boettcher M, Nowotny B, Krausche R, et al. Evaluation of the influence of sildenafil on the safety, tolerability, pharmacokinetics, and pharmacodynamics of vericiguat in healthy adults. Clin Pharmacokinet. 2023;62:321–33. https://doi.org/10.1007/s40262-022-01203-5.
Oyelade BO, Jemilohun AC, Aderibigbe SA. Prevalence of erectile dysfunction and possible risk factors among men of south-western Nigeria: a population-based study. Pan Afr Med J. 2016. https://doi.org/10.11604/PAMJ.2016.24.124.8660.
Sathyanarayana Rao TS, Darshan MS, Tandon A. An epidemiological study of sexual disorders in South Indian rural population. Indian J Psychiatry. 2015;57:150–7.
Zhang X, Yang B, Li N, et al. Prevalence and risk factors for erectile dysfunction in Chinese adult males. J Sex Med. 2017;14:1201–8.
Andrade C. Sample size and its importance in research. 2020;42:102–3. https://doi.org/10.4103/IJPSYM.IJPSYM_504_19.
Murtadha M, Raslan MA, Fahmy SF, et al. Changes in the pharmacokinetics and pharmacodynamics of sildenafil in cigarette and cannabis smokers. Pharmaceutics. 2021;13:876.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No external funding was used in the preparation of this letter.
Conflict of Interest
Dr Mustafa Ganijee, Gaayen Ravii Sahgal, Bilal Latif and Malik Takreem Ahmad declare that they have no potential conflicts of interest that might be relevant to the contents of this letter.
Authors' Contributions
MG: conceptualisation and supervision. GRS: analysis and writing. BL: writing. MTA: reviewing and editing.
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Data Availability Statement
Data sharing is not applicable to this article, as no datasets were generated for this letter.
Code Availability
Not applicable.
Rights and permissions
About this article
Cite this article
Ganijee, M., Sahgal, G.R., Latif, B. et al. Comment on: Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults. Clin Pharmacokinet 62, 1649–1650 (2023). https://doi.org/10.1007/s40262-023-01303-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40262-023-01303-w